AdvanSource Biomaterials Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and AdvanSource Biomaterials are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days AdvanSource Biomaterials has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, AdvanSource Biomaterials is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
AdvanSource |
AdvanSource Biomaterials Relative Risk vs. Return Landscape
If you would invest (100.00) in AdvanSource Biomaterials on October 4, 2025 and sell it today you would earn a total of 100.00 from holding AdvanSource Biomaterials or generate -100.0% return on investment over 90 days. AdvanSource Biomaterials is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than AdvanSource, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AdvanSource Biomaterials Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AdvanSource Biomaterials' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as AdvanSource Biomaterials, and traders can use it to determine the average amount a AdvanSource Biomaterials' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ASNB |
Based on monthly moving average AdvanSource Biomaterials is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AdvanSource Biomaterials by adding AdvanSource Biomaterials to a well-diversified portfolio.
AdvanSource Biomaterials Fundamentals Growth
AdvanSource Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of AdvanSource Biomaterials, and AdvanSource Biomaterials fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AdvanSource Pink Sheet performance.
| Return On Equity | -51.46 | |||
| Return On Asset | -495.48 | |||
| Current Valuation | 4.83 M | |||
| Shares Outstanding | 5.68 M | |||
| Price To Earning | 8.24 X | |||
| Price To Book | 37.43 X | |||
| Price To Sales | 0.35 X | |||
| EBITDA | (287 K) | |||
| Cash And Equivalents | 186 K | |||
| Cash Per Share | 0.03 X | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (282 K) | |||
| Earnings Per Share | (0.52) X | |||
| Total Asset | 250 K | |||
| Retained Earnings | (37.82 M) | |||
| Current Asset | 579 K | |||
| Current Liabilities | 591 K | |||
Things to note about AdvanSource Biomaterials performance evaluation
Checking the ongoing alerts about AdvanSource Biomaterials for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for AdvanSource Biomaterials help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AdvanSource Biomaterials is not yet fully synchronised with the market data | |
| AdvanSource Biomaterials has some characteristics of a very speculative penny stock | |
| AdvanSource Biomaterials has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (287 K) with profit before overhead, payroll, taxes, and interest of 2.47 M. | |
| AdvanSource Biomaterials currently holds about 186 K in cash with (282 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 90.0% of the company shares are held by company insiders |
- Analyzing AdvanSource Biomaterials' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AdvanSource Biomaterials' stock is overvalued or undervalued compared to its peers.
- Examining AdvanSource Biomaterials' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AdvanSource Biomaterials' management team can have a significant impact on its success or failure. Reviewing the track record and experience of AdvanSource Biomaterials' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AdvanSource Biomaterials' pink sheet. These opinions can provide insight into AdvanSource Biomaterials' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in AdvanSource Pink Sheet
If you are still planning to invest in AdvanSource Biomaterials check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AdvanSource Biomaterials' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |